Atb Cap Markets Predicts Stronger Earnings for Canopy Growth

Key Points

• ATB Capital Markets has raised its Q2 2026 earnings per share estimate for Canopy Growth from ($0.22) to ($0.15), indicating a more favorable outlook for the company.
• The consensus estimate for Canopy Growth's full-year earnings has been set at ($2.81) per share, highlighting ongoing challenges for the company despite the revised projections.
• Shares of Canopy Growth opened at $1.58 with a market capitalization of approximately $324.96 million, reflecting investor interest amid the company's restructuring efforts and recent earnings updates.

Canopy Growth Corporation (NASDAQ:CGC - Free Report) - Equities research analysts at Atb Cap Markets boosted their Q2 2026 EPS estimates for Canopy Growth in a report released on Sunday, August 10th. Atb Cap Markets analyst F. Gomes now anticipates that the company will earn ($0.15) per share for the quarter, up from their previous forecast of ($0.22). The consensus estimate for Canopy Growth's current full-year earnings is ($2.81) per share. Atb Cap Markets also issued estimates for Canopy Growth's Q3 2026 earnings at ($0.13) EPS, Q4 2026 earnings at ($0.12) EPS, FY2026 earnings at ($0.56) EPS, FY2027 earnings at ($0.36) EPS, FY2028 earnings at ($0.13) EPS, FY2029 earnings at ($0.08) EPS and FY2030 earnings at ($0.05) EPS.

Several other research firms have also recently commented on CGC. Piper Sandler restated an "underweight" rating on shares of Canopy Growth in a report on Friday, May 30th. Zacks Research raised Canopy Growth to a "hold" rating in a research report on Tuesday, August 12th.

Canopy Growth Price Performance

Canopy Growth stock traded up $0.07 during midday trading on Wednesday, reaching $1.37. 22,284,384 shares of the company were exchanged, compared to its average volume of 9,922,523. The company has a market capitalization of $328.59 million, a price-to-earnings ratio of -0.45 and a beta of 0.67. The firm's 50-day simple moving average is $1.24 and its 200-day simple moving average is $1.34. Canopy Growth has a 1 year low of $0.77 and a 1 year high of $7.08. The company has a debt-to-equity ratio of 0.59, a quick ratio of 2.12 and a current ratio of 3.07.

Canopy Growth (NASDAQ:CGC - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.14) EPS for the quarter, beating analysts' consensus estimates of ($0.15) by $0.01. The company had revenue of $52.98 million during the quarter, compared to the consensus estimate of $64.98 million. Canopy Growth had a negative return on equity of 89.93% and a negative net margin of 155.76%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP acquired a new position in shares of Canopy Growth in the 4th quarter valued at $41,000. Two Sigma Securities LLC increased its holdings in shares of Canopy Growth by 150.1% during the 4th quarter. Two Sigma Securities LLC now owns 26,517 shares of the company's stock valued at $73,000 after acquiring an additional 15,916 shares during the last quarter. Bayesian Capital Management LP acquired a new position in shares of Canopy Growth during the 4th quarter valued at about $75,000. Centiva Capital LP increased its holdings in shares of Canopy Growth by 133.1% during the 4th quarter. Centiva Capital LP now owns 124,155 shares of the company's stock valued at $340,000 after acquiring an additional 70,884 shares during the last quarter. Finally, Tidal Investments LLC increased its holdings in shares of Canopy Growth by 12.5% during the 4th quarter. Tidal Investments LLC now owns 2,263,873 shares of the company's stock valued at $6,203,000 after acquiring an additional 251,659 shares during the last quarter. Institutional investors own 3.33% of the company's stock.

Canopy Growth Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.